Soricimed Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Soricimed General Information

Description

Operator of a clinical-stage drug development company intended to provide novel targeted treatments for cancer. The company offers a selective calcium channel present in high amounts on the surface of solid tumor cancer cells and required for the growth, metastasis and resistance to programmed cell death, enabling healthcare professionals to induce apoptosis, inhibit cell proliferation and reduce tumor volume while minimizing side effects associated with typical chemotherapy.

Contact Information

Website
www.soricimed.com
Formerly Known As
BioProspecting NB
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 18 Botsford Street
  • Suite 201
  • Moncton, New Brunswick E1C 4W7
  • Canada
+1 (506)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 18 Botsford Street
  • Suite 201
  • Moncton, New Brunswick E1C 4W7
  • Canada
+1 (506)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Soricimed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator Completed Clinical Trials - Phase 1
4. Later Stage VC 18-Jan-2023 Completed Clinical Trials - Phase 1
3. Later Stage VC 01-Jan-2020 Completed Clinical Trials - General
2. Seed Round 18-Oct-2011 $7M $7M Completed Clinical Trials - General
1. Grant 23-Jun-2010 $5M Completed Startup
To view Soricimed’s complete valuation and funding history, request access »

Soricimed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage drug development company intended to provide novel targeted treatments for cancer. The comp
Drug Discovery
Moncton, Canada
8 As of 2022

Redwood City, CA
 

Lake Forest, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Soricimed Competitors (107)

One of Soricimed’s 107 competitors is Adverum Biotechnologies, a Formerly VC-backed company based in Redwood City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adverum Biotechnologies Formerly VC-backed Redwood City, CA
Jaguar Gene Therapy Venture Capital-Backed Lake Forest, IL
Kymera Therapeutics Formerly VC-backed Watertown, MA
Repertoire Immune Medicines Venture Capital-Backed Cambridge, MA
NexImmune Formerly VC-backed Gaithersburg, MD
You’re viewing 5 of 107 competitors. Get the full list »

Soricimed Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Soricimed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2300625-T3 Paralyzing peptide of musaraña for use in neuromuscular therapy. Inactive 18-Nov-2002
US-20080045458-A1 Synthetic polypeptides; isolated and purified from the submaxiliary saliva glands of shrews of the species blarina as a paralytic agent for reducing wrinkles; inhibits calcium uptake; encoded from nucleic acid; analgesic or insecticide Inactive 18-Nov-2002
US-20080081784-A1 Administering to the cell a peptide isolated from the submaxiliary saliva glands of shrews of the species blarina as a paralytic agent for reducing wrinkles; inhibits calcium uptake Inactive 18-Nov-2002
EP-1601691-B1 Shrew paralytic peptide for use in neuromuscular therapy Inactive 18-Nov-2002
EP-1601691-A2 Shrew paralytic peptide for use in neuromuscular therapy Active 18-Nov-2002 C07K14/47
To view Soricimed’s complete patent history, request access »

Soricimed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Soricimed Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
New Brunswick Innovation Foundation Not-For-Profit Venture Capital Minority
National Research Council Canada Government
CELS Valley Ready Accelerator/Incubator
To view Soricimed’s complete investors history, request access »

Ready to get started?

Request a free trial

Soricimed FAQs

  • When was Soricimed founded?

    Soricimed was founded in 2005.

  • Where is Soricimed headquartered?

    Soricimed is headquartered in Moncton, Canada.

  • What is the size of Soricimed?

    Soricimed has 8 total employees.

  • What industry is Soricimed in?

    Soricimed’s primary industry is Drug Discovery.

  • Is Soricimed a private or public company?

    Soricimed is a Private company.

  • What is Soricimed’s current revenue?

    The current revenue for Soricimed is .

  • How much funding has Soricimed raised over time?

    Soricimed has raised $10M.

  • Who are Soricimed’s investors?

    New Brunswick Innovation Foundation, National Research Council Canada, and CELS Valley Ready have invested in Soricimed.

  • Who are Soricimed’s competitors?

    Adverum Biotechnologies, Jaguar Gene Therapy, Kymera Therapeutics, Repertoire Immune Medicines, and NexImmune are some of the 107 competitors of Soricimed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »